Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Open to debate. The motion: PDE5 inhibitors will have a significant role in the treatment of BPH.

× No keyword cloud information.

5 in total

Review 1. Management of benign prostatic hyperplasia: role of phosphodiesterase-5 inhibitors.

Authors: M Gacci; M Carini; M Salvi; A Sebastianelli; L Vignozzi; G Corona; M Maggi; K T McVary; S A Kaplan; M Oelke; S Serni
Journal: Drugs Aging Date: 2014-06 Impact factor: 3.923

Review 2. Novel drug targets for the pharmacotherapy of benign prostatic hyperplasia (BPH).

Authors: S Ventura; V l Oliver; C W White; J H Xie; J M Haynes; B Exintaris
Journal: Br J Pharmacol Date: 2011-07 Impact factor: 8.739

3. Efficacy and Safety of Tadalafil 5 mg Administered Once Daily in Korean Men with Erectile Dysfunction: A Prospective, Multicenter Study.

Authors: Dong Hyuk Kang; Joo Yong Lee; Sung Yul Park; Hong Sang Moon; Tae Yoong Jeong; Tag Keun Yoo; Hong Yong Choi; Hae Young Park; Tchun Yong Lee; Seung Wook Lee
Journal: Korean J Urol Date: 2010-09-17

4. PDE5-Is for the Treatment of Concomitant ED and LUTS/BPH.

Authors: M Gacci; A Sebastianelli; M Salvi; L Vignozzi; G Corona; K T McVary; S A Kaplan; M Oelke; M Maggi; M Carini
Journal: Curr Bladder Dysfunct Rep Date: 2013-06

5. Tadalafil vs. tamsulosin in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a prospective, randomized study.

Authors: Vedamurthy Reddy Pogula; Lalith Sagar Kadiyala; Vijayabhaskar Reddy Gouru; Sivasankar Reddy Challa; Ranadheer Byram; Sudeep Bodduluri
Journal: Cent European J Urol Date: 2019-03-14

5 in total